In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset
K Harada
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorJ Van de Water
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorP S Leung
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorR L Coppel
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorA Ansari
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorY Nakanuma
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorM E Gershwin
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorK Harada
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorJ Van de Water
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorP S Leung
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorR L Coppel
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorA Ansari
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorY Nakanuma
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorM E Gershwin
Division of Rheumatology, Allergy and Clinical Immunology, School of Medicine, University of California, Davis 95616, USA
Search for more papers by this authorAbstract
Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by destruction of the intrahepatic bile ducts. It is generally believed that cellular immune mechanisms, particularly involving T cells, result in this bile duct damage. The relative strength of Th1 and Th2 responses has recently been proposed to be an important factor in the pathophysiology of various autoimmune diseases. In this study, we have attempted to identify the Th subset balance in PBC, by detection of cytokines specific to the two T-cell subsets, i.e., interferon γ (IFN-γ) for Th1 cells and interleukin-4 (IL-4) for Th2 cells. We analyzed IFN-γ and IL-4 messenger RNA (mRNA) positive cells in liver sections from 18 patients with PBC and 35 disease controls including chronic active hepatitis C, extrahepatic biliary obstruction (EBO), and normal liver, using nonisotopic in situ hybridization and immunohistochemistry. Mononuclear cells expressing IFN-γ and IL-4 mRNA were aggregated in inflamed portal tracts in PBC livers, but were rarely present in extrahepatic biliary obstruction, alcoholic fibrosis, or normal liver sections. The IFN- γ and IL-4 mRNA positive cells in PBC livers were detected in significantly higher numbers than in control livers (P < .01). Moreover, IFN-γ mRNA expression was more commonly detected than IL-4 expression in PBC livers, and the levels of IFN-γ mRNA expression were highly correlated with the degree of portal inflammatory activity. IFN-γ mRNA-positive cells were detected primarily around damaged bile ducts that were surrounded by lymphoid aggregates. The data indicate that Th1 cells are the more prominent T-cell subset in the lymphoid infiltrates in PBC.
References
- 1 Scheuer PJ. Liver Biopsy Interpretation. London: Bailliere-Tindall, 1980.
- 2 Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis. Am J Pathol 1965; 46: 387–407.
- 3 Kaplan MM, Gandolfo JV, Quaroni EG. An enzyme-linked immunosorbent assay (ELISA) for detecting antimitochondrial antibody. Hepatology 1984; 4: 727–730.
- 4 Van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL. The auto-epitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyl transfer as e. J Exp Med 1988; 167: 1791–1799.
- 5 Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138: 3525–3531.
- 6 Van de Water J, Ansari AA, Surh CD, Coppel R, Roche T, Bonkovsky H, Kaplan M, et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol 1991; 146: 89–94.
- 7 Gershwin ME, Mackay IR. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 1991; 100: 822–833.
- 8 Yamada G, Hyodo I, Tobe K, Mizuno M, Nishihara T, Kobayashi T, Naga-shima H. Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology 1986; 6: 385–391.
- 9 Van den Oord JJ, Fevery J, de Groote J, Desmet VJ. Immunohistochemical characterization of inflammatory infiltrates in primary biliary cirrhosis. Liver 1984; 4: 264–274.
- 10 Krams SM, Van de Water J, Coppel RL, Esquivel C, Roberts J, Ansari A, Gershwin ME. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology 1990; 12: 306–313.
- 11 Bjorkland A, Festin R, Mendel-Hartvig I, Nyberg A, Loof L, Totterman TH. Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells. Hepatology 1991; 13: 1106–1111.
- 12 Mosmann T, Cherwinski H, Bond M, Giedlin M, RL Coffmann. Two types of murine helper T cell clone I. Definition according to profiles of lympho-kine activities and secreted proteins. J Immunol 1986; 136: 2348–2357.
- 13 Cherwinski H, Schumacher J, Brown K, Mosmann T. Two types of mouse helper T cell clone III. Further differences in lymphokine synthesis between Thl and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987; 166: 1229–1244.
- 14 Fiorentine D, Bond M, Mosmann T. Two types of mouse T helper cell clone IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones. J Exp Med 1989; 170: 2081–2095.
- 15 Paul W, Seder R. Lymphocyte responses and cytokines. Cell 1994; 76: 241–251.
- 16 Van de Water J, Ansari A, Prindiville T, Coppel R, Ricalton N, Kotzin BL, Liu S, et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995; 181: 723–733.
- 17 Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Archiv A, Pathol Anat Histol 1978; 379: 103–112.
- 18 Chomezyneski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159.
- 19 Yokota T, Otsuka T, Mosmann T, Banchereau J, DeFrance T, Blanchard D, DeVries J, et al. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci U S A 1986; 83: 5894–5898.
- 20 Paolella G, Santamaria R, Izzo P, Costanzo P, Salvatore F. Isolation and nucleotide sequence of a full-length cDNA coding for aldolase B from human liver. Nucleic Acid Res 1984; 12: 7401–7410.
- 21 Gray P, Leung D, Pennica D, Yelverton E, Najarian R, Simonsen C, De-rynck R, et al. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 1982; 295: 503–508.
- 22 Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A 1985; 82: 6133–6137.
- 23 Hsu M, Raine L, Frager H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unla-beled (PAP) procedures. J Histochem Cytochem 1981; 29: 557–580.
- 24 Bishop G, Rokahr K, Napoli J, McCaughan G. Intragraft cytokine mRNA levels in human liver allograft rejection analyzed by reverse transcription polymerase chain reaction amplification. Transplant Immunol 1993; 1: 253–261.
- 25 Morshed S, Fukuma H, Kimura Y, Watanabe S, Nishioka M. Interferon-gamma, interleukin (IL)-2 and IL-2 receptor expressions in hepatitis C virus-infected liver. Gastroenterologia Japonica 1993; 28 (Suppl 5): 59–66.
- 26 Shimizu M, Yuh K, Aoyama S, Ichihara I, Watanabe H, Shijo H, Okumura M. Immunohistochemical characterization of inflammatory infiltrates at the site of bile duct injury in primary biliary cirrhosis. Liver 1986; 6: 1–6.
- 27 Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, Ludwig J. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis [see comments]. Mayo Clin Proc 1993; 68: 1049–1055.
- 28 Lohr HF, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Meyer zum Buschenfelde KH. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994; 14: 161–166.
- 29 Kaneko H. Immunohistochemical analysis of immune abnormalities on the mechanism of bile duct destruction in primary biliary cirrhosis. Acta HepatolJpn 1996; 19: 697–705.
- 30 Sinha A, Lopez M, McDevitt H. Autoimmune diseases: the failure of self tolerance. Science 1990; 248: 1380–1388.
- 31 Fukuda R, Ishimura N, Nguyen T, Chowdhury A, Ishihara S, Kohge N, Akagi S, et al. The expression of IL-2, IL-4 and interferon-gamma (IFN-gamma) mRNA using liver biopsies at different phases of acute exacerbation of chronic hepatitis B. Clin Exp Immunol 1995; 100: 446–451.
- 32 Schlaak JF, Lohr H, Gallati H, Meyer zum Buschenfelde KH, Fleischer B. Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol 1993; 94: 168–173.
- 33 Hernandez-Pando R, Rook G. The role of TNF-α in T-cell-mediated inflammation depends on the Thl/Th2 cytokine balance. Immunol 1994; 82: 591–595.
- 34 Maraskovsky E, Chen W-F, Shortman K. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. J Immunol 1989; 143: 1210–1214.
- 35 Farrar MA, Schreiber RD. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 1993; 11: 571–611.
- 36 Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984; 2: 1009–1013.
- 37 Nakanuma Y, Kono N. Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: an immunohistochemical study. Hum Pathol 1991; 22: 431–436.
- 38 Valerius T, Repp R, Kaldenmn J, Platzer E. Effects of IFN on human eosinophils in comparison with other cytokines: a novel class of eosinophil activators with delayed onset of action. J Immunol 1990; 145: 2950–2958.
- 39 Terasaki S, Nakanuma Y, Yamazaki M, Unoura M. Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study. Hepatology 1993; 17: 206–212.
- 40 Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113–119.